<?xml version="1.0" encoding="UTF-8"?>
<p>Patients' information, the severity of symptoms, and quality of life were recorded in a special form at the baseline, end, and two weeks after the end of the treatment. The daily severity of EPS and PDS in the week before the start and end of the intervention were scored using NRS from 0 (no symptoms) to 10 (the most severe symptoms), and the sufficient response to treatment as the primary outcome was defined as a mean NRS score â‰¤3 in seven days before the end of the intervention [
 <xref rid="B28" ref-type="bibr">28</xref>]. Also, symptom severity was assessed using the Gastrointestinal Symptom Rating Scale (GSRS). To determine the effect of treatment on patients' quality of life, they were asked to complete the 36-Item Short-Form Health Survey (SF-36).
</p>
